Myocardial salvaging effects and mechanisms of dipeptidyl peptidase-IV inhibitor Vildagliptin in experimental diabetes. (2016). International Journal of Biomedical Research, 7(5), 276-282. https://doi.org/10.7439/ijbr.v7i5.3273